Michael Tainsky
13Patents
5h-index
8Co-inventors
59Inventor score
Filing activity: Oct 13, 1992 → Oct 17, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6017524A | Inhibiting the growth p53 deficient tumor cells by administering the p53 gene | Human Necessities | 17 | Expired |
| US6627189B1 | Inhibition of cellular proliferation using ras antisense molecules | Human Necessities | 16 | Expired |
| US6998117B1 | Cancer treatment with retroviral vectors comprising wild-type p53 | Human Necessities | 6 | Expired |
| US6436700B1 | Anti-sense p21 k-ras | Human Necessities | 5 | Expired |
| US7863004B2 | Neoepitope detection of disease using protein arrays | Emerging Cross-Sectional Technologies | 5 | Expired |
| US8614169B2 | Neoepitope detection of disease using protein arrays | Physics | 0 | Active |
| US7964536B2 | Neoepitope detection of disease using protein arrays | Emerging Cross-Sectional Technologies | 0 | Active |
| US9575070B2 | Neoepitope detection of disease using protein arrays | Physics | 0 | Active |
| US9222938B2 | Neoepitope detection of disease using protein arrays | Physics | 0 | Active |
| US10782302B2 | Detectors of serum biomarkers for predicting ovarian cancer recurrence | Human Necessities | 0 | Active |
| US8753822B2 | Neoepitope detection of disease using protein arrays | Physics | 0 | Active |
| US10302646B2 | Neoepitope detection of disease using protein arrays | Physics | 0 | Active |
| US9797906B2 | Detectors of serum biomarkers for predicting ovarian cancer recurrence | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.